Gene Therapy Guidances From US FDA Coming In About 6 Weeks, Gottlieb Says

Potential accelerated approval endpoints will be addressed; FDA Commissioner expects gene therapy to become a 'backbone' treatment as antibodies are now.

Scott Gottlieb speaking at Financial Times US Healthcare & Life Sciences Summit
Financial Times Senior US Business Correspondent David Crow and FDA Commissioner Scott Gottlieb • Source: Brenda Sandburg

More from Approval Standards

More from Pathways & Standards